References of "Petermans, Jean"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detaillES CHUTES DE LA PERSONNE AGEE
GILLAIN, Sophie ULg; ELBOUZ, Leila ULg; Beaudart, Charlotte ULg et al

in Revue Médicale de Liège (in press)

Detailed reference viewed: 79 (23 ULg)
Full Text
Peer Reviewed
See detailDépister la fragilité, un bénéfice pour le patient et pour le soignant
RICOUR, Céline ULg; DESAINTHUBERT, Marie; GILLAIN, Sophie ULg et al

in Revue Médicale de Liège (in press)

Detailed reference viewed: 49 (11 ULg)
Full Text
Peer Reviewed
See detailPLACE DE LA GERIATRIE DANS LA FILIERE DES SOINS
PETERMANS, Jean ULg

in Revue Médicale de Liège (in press)

Detailed reference viewed: 46 (17 ULg)
Full Text
Peer Reviewed
See detailPLACE DE LA GERIATRIE DANS LA FILIERE DES SOINS
PETERMANS, Jean ULg

in Revue Médicale de Liège (in press)

Detailed reference viewed: 46 (17 ULg)
Full Text
Peer Reviewed
See detailPLACE DE LA GERIATRIE DANS LA FILIERE DES SOINS
PETERMANS, Jean ULg

in Revue Médicale de Liège (in press)

Detailed reference viewed: 46 (17 ULg)
See detailLe syndrome dysexécutif pour les nuls
Adam, Stéphane; SALMON, Eric ULg; GILLAIN, Sophie ULg et al

Conference (2015, January 15)

Detailed reference viewed: 9 (0 ULg)
Full Text
Peer Reviewed
See detailEducation et formation en médecine gériatrique en Europe : challenge du futur?
ROLLER, REGINA ELISABETH; PETERMANS, Jean ULg

in Gériatrie et Psychologie Neuropsychiatrie du Vieillissement (2015)

Detailed reference viewed: 23 (0 ULg)
Full Text
Peer Reviewed
See detailValidation des paramètres de marche par un système accélérométrique (Locométrix*) à l'aide d'un système opto-électronique 3D (Coda Motion )
GILLAIN, Sophie ULg; Schwartz, Cédric ULg; Boutaayamou, Mohamed ULg et al

in Gériatrie et Psychologie Neuropsychiatrie du Vieillissement (2014), 12(supplément 3),

Detailed reference viewed: 36 (8 ULg)
See detailLe syndrome post-chute en images : diagnostic et prise en charge
GILLAIN, Sophie ULg; ELBOUZ, Leila ULg; PETERMANS, Jean ULg

Scientific conference (2014, May 17)

Detailed reference viewed: 29 (2 ULg)
See detailPsychogériatrie : à la croisée entre gériatrie et psychiatrie
Adam, Stéphane ULg; Schuerch, Mike ULg; PETERMANS, Jean ULg

Conference (2014, January 16)

Detailed reference viewed: 20 (1 ULg)
Full Text
Peer Reviewed
See detailEstimation of sarcopenia prevalence using various assessment tools
Beaudart, Charlotte ULg; Reginster, Jean-Yves ULg; Slomian, Justine ULg et al

in Experimental Gerontology (2014), 61

BACKGROUND: Sarcopenia is defined as a progressive and generalized loss of muscle mass with either a loss of muscle strength or a loss of physical performance but there is no recommendation regarding the ... [more ▼]

BACKGROUND: Sarcopenia is defined as a progressive and generalized loss of muscle mass with either a loss of muscle strength or a loss of physical performance but there is no recommendation regarding the diagnostic tools that have to be used. In this study, we compared the prevalence of sarcopenia assessed using different diagnostic tools. METHODS: To measure muscle mass, muscle strength and physical performance, we used for each outcome two different diagnostic tools. For muscle mass, we used Dual Energy X-Ray Absorptiometry (DXA) and bio-electrical impedance analysis (BIA); for muscle strength, we used a hydraulic dynamometer and a pneumatic dynamometer; for physical performance we used the Short Physical Performance Battery test (SPPB test) and the walk speed. Eight diagnostic groups were hereby established. RESULTS: A total of 250 consecutive subjects were recruited in an outpatient clinic in Liège, Belgium. Estimated prevalence of sarcopenia varied from 8.4% to 27.6% depending on the method of diagnosis used. Regarding muscle mass, BIA systematically overestimated muscle mass compared to DXA (mean estimated prevalence with BIA=12.8%; mean prevalence with DXA=21%). For muscle strength, the pneumatic dynamometer diagnosed twice more sarcopenic subjects than the hydraulic dynamometer (mean estimated prevalence with PD=22.4%; mean estimated prevalence with HD=11.4%). Finally, no difference in prevalence was observed when the walking speed or the SPPB test was used. A weak overall kappa coefficient was observed (0.53), suggesting that the 8 methods of diagnosis are moderately concordant. CONCLUSION: Within the same definition of sarcopenia, prevalence of sarcopenia is highly dependent on the diagnostic tools used. [less ▲]

Detailed reference viewed: 26 (13 ULg)
Full Text
Peer Reviewed
See detailValidation des paramètres de marche par un système accélérométrique (Locométrix) à l’aide d’un système opto-électronique 3D (Coda Motion)
GILLAIN, Sophie ULg; Schwartz, C; Dramé, M et al

in Cahiers de l'Année Gérontologique (Les) (2014), 2(23), 724-73

Detailed reference viewed: 10 (4 ULg)
Full Text
Peer Reviewed
See detailThe effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials.
Beaudart, Charlotte ULg; Buckinx, Fanny ULg; Rabenda, Véronique ULg et al

in The Journal of clinical endocrinology and metabolism (2014), 99(11), 4336-4345

Context There is growing evidence that vitamin D plays a role on several tissues including skeletal muscle. Objective To summarize with a meta-analyse the effects of vitamin D supplementation on muscle ... [more ▼]

Context There is growing evidence that vitamin D plays a role on several tissues including skeletal muscle. Objective To summarize with a meta-analyse the effects of vitamin D supplementation on muscle function. Data sources A systematic research of randomized controlled trials, performed between 1966 and January 2014 has been conducted on Medline, Cochrane Database of Systematics Reviews, Cochrane Central Register of Controlled and completed by a manual review of the literature and congressional abstracts. Study selection All forms and doses of vitamin D supplementation, with or without calcium supplementation, compared with placebo or control were included. Out of the 225 potentially relevant articles, 30 randomized controlled trials involving 5615 individuals (mean age: 61.1 years) met the inclusion criteria. Data extraction Data were extracted by two independent reviewers. Data synthesis Results revealed a small but significant positive effect of vitamin D supplementation on global muscle strength with a standardized mean difference (SMD) of 0.17 (p=0.02). No significant effect was found on muscle mass (SMD 0.058; p=0.52) or muscle power (SMD 0.057; p=0.657). Results on muscle strength were significantly more important with people who presented a 25-hydroxyvitamin D level <30 nmol/L. Supplementation seems also more effective on people aged 65 years or older compared to younger subjects (SMD 0.25; 95% CI 0.01 to 0.48 versus SMD 0.03; 95% CI -0.08 to 0.14). Conclusions Vitamin D supplementation has a small positive impact on muscle strength but additional studies are needed to define optimal treatment modalities, including dose, mode of administration and duration. [less ▲]

Detailed reference viewed: 44 (19 ULg)
Full Text
Peer Reviewed
See detailErratum to: Management of osteoporosis of the oldest old
Rizzoli, R; Branco, J; Brandi, ML et al

in Osteoporosis International (2014), 25

Detailed reference viewed: 13 (2 ULg)